VibioSPhen
Year Established:
2014 |
|
Website:
vibiosphen.com |
|
Headquarters:
LABEGE, , FR |
|
Company Type:
Small Business (1-10M TTM Revenue) |
|
Completed Requests:
14 |
|
Open Requests:
5 |
|
Certifications:
|
Vibiosphen is a French biotechnology company specialized in infectious diseases. • BACTERIA • FUNGI • VIRUS •
We combine expertise in microbiology, molecular biology and pharmacology (in vitro and in vivo) with experience in drug R&D in the field of infectious diseases, immunomodulation and host-pathogen interaction
Our preclinical services start from in vitro to in vivo testing
•In vitro Efficacy and cytotoxicity • Organoids Efficacy and cytotoxicity • In vivo MTD & PK/PD studies and efficacy models•
• Efficacy test in vitro : MIC, MBC, TKC, antibiogram,
• Host-pathogen interaction, adhesion / invasion assay,
• In vitro safety assessment: Cell viability, hemolysis assays,
• In vivo MDT and PK/PD studies
• In vivo preclinical models: bacteria, viruses, fungi, in house and on demand. BSL2 and BSL3
• Vaccine development support.
Vibiosphen has at disposal, in this high technical and scientific quality environment with BSL2 and BSL3 laboratories and facilities.
Vibiosphen provides services drawing on cutting-edge technology to create predictive and translational models for studying small molecules, vaccine or biologics
Site | Badges | |
---|---|---|
VibioSPhen 516 Rue Pierre et Marie Curie Labège, Midi-Pyrénées, 31670 France | ||
VibioSPhen Prologue Biotech LABEGE, , 31670 France |
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.